EE200000072A - Insuliini C-peptiidi rekombinantne ekspressioon - Google Patents

Insuliini C-peptiidi rekombinantne ekspressioon

Info

Publication number
EE200000072A
EE200000072A EEP200000072A EEP200000072A EE200000072A EE 200000072 A EE200000072 A EE 200000072A EE P200000072 A EEP200000072 A EE P200000072A EE P200000072 A EEP200000072 A EE P200000072A EE 200000072 A EE200000072 A EE 200000072A
Authority
EE
Estonia
Prior art keywords
insulin
peptide
recombinant expression
recombinant
expression
Prior art date
Application number
EEP200000072A
Other languages
English (en)
Inventor
St�hl Stefan
Uhl�n Mathias
Nygren Per-Ke
Jonasson Per
Original Assignee
Creative Peptides Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab
Publication of EE200000072A publication Critical patent/EE200000072A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200000072A 1997-08-07 1998-08-07 Insuliini C-peptiidi rekombinantne ekspressioon EE200000072A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716790.2A GB9716790D0 (en) 1997-08-07 1997-08-07 Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
PCT/GB1998/002382 WO1999007735A2 (en) 1997-08-07 1998-08-07 Recombinant expression of insulin c-peptide

Publications (1)

Publication Number Publication Date
EE200000072A true EE200000072A (et) 2000-10-16

Family

ID=10817184

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000072A EE200000072A (et) 1997-08-07 1998-08-07 Insuliini C-peptiidi rekombinantne ekspressioon

Country Status (21)

Country Link
US (1) US6558924B1 (et)
EP (1) EP1001980A1 (et)
JP (1) JP2001512745A (et)
KR (1) KR20010022590A (et)
CN (1) CN1268141A (et)
AU (1) AU750685B2 (et)
BG (1) BG104161A (et)
BR (1) BR9811850A (et)
CA (1) CA2297382A1 (et)
EA (1) EA200000202A1 (et)
EE (1) EE200000072A (et)
GB (1) GB9716790D0 (et)
HU (1) HUP0004626A1 (et)
IL (1) IL134372A0 (et)
IS (1) IS5368A (et)
NO (1) NO20000575L (et)
NZ (1) NZ502450A (et)
PL (1) PL339085A1 (et)
SK (1) SK1532000A3 (et)
TR (1) TR200000288T2 (et)
WO (1) WO1999007735A2 (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005669A1 (en) * 1997-08-07 2004-01-08 Stefan Stahl Recombinant expression of insulin C-peptide
FR2810674A1 (fr) * 2000-06-22 2001-12-28 Pf Medicament Construction modifiee en amont du codon d'initiation pour la surexpression de proteines recombinantes
FR2810675B1 (fr) * 2000-06-22 2002-09-27 Pf Medicament Construction modifiee en aval du codon d'initiation pour la surexpression de proteines recombinantes
AU2002233230B2 (en) * 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates
CA2475388A1 (en) * 2002-02-14 2003-08-21 William J. Rutter Chimeric molecules for cleavage in a treated host
CN100558398C (zh) 2002-11-26 2009-11-11 拜奥康有限公司 修饰的钠尿化合物、缀合物及其应用
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides
US7795384B2 (en) * 2003-06-03 2010-09-14 Shanghai Centre Of Research & Development Of New Drugs Fusion protein suitable for high efficiency expression and the production method thereof
AU2005222395B2 (en) * 2004-03-10 2012-02-16 Creighton University Estrogen receptors and methods of use
MX2012013375A (es) 2010-05-17 2013-04-11 Cebix Inc Peptido c pegilado.
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽
SG11201405721VA (en) * 2012-03-19 2014-10-30 Madeleine Pharmaceuticals Ρτy Ltd Method of producing a recombinant peptide
WO2016145389A1 (en) 2015-03-12 2016-09-15 Board Of Trustees Of Michigan State University Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
CN109705221B (zh) * 2018-12-27 2021-03-09 美康生物科技股份有限公司 C肽免疫原及其单克隆抗体对及该抗体对在c肽磁微粒化学发光免疫试剂中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210872B2 (et) * 1973-07-14 1977-03-26
GB2068971B (en) 1980-01-30 1983-06-08 Searle & Co Recombinant dna techniques
CA1213537A (en) 1984-05-01 1986-11-04 Canadian Patents And Development Limited - Societe Canadienne Des Brevets Et D'exploitation Limitee Polypeptide expression method
JPH02500876A (ja) 1987-03-20 1990-03-29 クリエイティブ・バイオマリキュールズ・インコーポレーテッド 組換えポリペプチドの製品およびその製造、単離および精製方法
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
SE501169C2 (sv) 1988-02-05 1994-11-28 Aake Nygren Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner
US5130236A (en) 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5595887A (en) 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
GB9015825D0 (en) 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
JPH07108232B2 (ja) 1990-10-09 1995-11-22 エム・ディ・リサーチ株式会社 ペプチド又は蛋白質の製造方法
US5953418A (en) 1995-06-14 1999-09-14 David Hall Providing selective data broadcast receiver addressability
EP0816510A4 (en) 1995-12-22 2001-04-11 Toray Industries PROCESS FOR PRODUCING BIOLOGICALLY ACTIVE FUSED PROTEINS

Also Published As

Publication number Publication date
CA2297382A1 (en) 1999-02-18
IS5368A (is) 2000-02-01
TR200000288T2 (tr) 2000-06-21
AU750685B2 (en) 2002-07-25
AU8640798A (en) 1999-03-01
EP1001980A1 (en) 2000-05-24
HUP0004626A1 (hu) 2001-04-28
NO20000575L (no) 2000-04-04
EA200000202A1 (ru) 2001-04-23
KR20010022590A (ko) 2001-03-26
NZ502450A (en) 2002-10-25
BG104161A (en) 2000-12-29
NO20000575D0 (no) 2000-02-04
BR9811850A (pt) 2000-08-08
WO1999007735A2 (en) 1999-02-18
WO1999007735A3 (en) 1999-04-29
GB9716790D0 (en) 1997-10-15
JP2001512745A (ja) 2001-08-28
US6558924B1 (en) 2003-05-06
PL339085A1 (en) 2000-12-04
CN1268141A (zh) 2000-09-27
IL134372A0 (en) 2001-04-30
SK1532000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
NO2006014I1 (no) Insulin glulisin
NO2010013I2 (no) Rekombinant FSH-CTP
BR9510090A (pt) Utilização de um adenovírus recombinante
DK0884053T3 (da) Stabile insulinpræparater
DE69829787D1 (de) Verbesserte Injektionsspritze
ATA101795A (de) Insulinanalogon-protamin-komplex
NO20002038D0 (no) Uløselig insulinsammensetning
FI952931A0 (fi) Insuliinianalogiformulaatioita
DE69827328D1 (de) Vormontierte Spritze
DK0963211T3 (da) Hypodermisk injektionssystem
FI972292A (fi) Diabeteksen hallinta
DE69815881D1 (de) Nasaler dilatator
FI970132A (fi) Injektioruisku
DE69810382D1 (de) Spritzennadel
EE200000072A (et) Insuliini C-peptiidi rekombinantne ekspressioon
DE69812588D1 (de) Medizinischer injektor
DE69816443D1 (de) Sicherheitsspritze
DE69838308D1 (de) Langwelliger VCSEL
NO976058L (no) Rekombinant mistellectin
NO952336D0 (no) Insulin analoger
DE69917011D1 (de) Handgelenkprothese
ATE283706T1 (de) ßGEGEN RACEMISIERUNG STABILISIERTE PHARMAZEUTISCHE ZUBEREITUNGEN VON CILANSETRONß
NO970576D0 (no) Selvdestruerende injeksjonsspröyte
NO974924D0 (no) Modifiserte polypeptider med öket immunogenisitet
FR2749172B1 (fr) Seringue hypodermique